Cataract Surgery

Femtosecond laser use shows very low rate of capsule tears
Femtosecond laser use shows very low rate of capsule tears
Making phaco platform transition increases surgical safety, efficiencyWhen his surgery center was in the market for a new phacoemulsification platform, medical director Jonathan Solomon, MD, decided to switch from a unit equipped with a flow-based peristaltic pump to technology that features a vacuum-based Venturi system (Stellaris PC, Bausch + Lomb).
Tips for successful surgery with secondary IOLsAphakic eyes that have no or inadequate capsular support can pose a significant challenge to cataract surgeons. Careful attention to the preoperative considerations, appropriate intraocular lens choices, surgical techniques, and postoperative management can ensure optimal results.
European study with microstent demonstrates lowered IOP, use of fewer drugsPatients with cataract surgery and microstent implantation had a lowered IOP and a reduced number of medications used at 3 years postoperatively
Pain-preventing NSAID welcomed by patients and cliniciansA new 0.075% formulation of bromfenac ophthalmic solution (BromSite, Sun Pharma) could provide relief from pain and inflammation associated with cataract surgery.
Dr. Mali's top 5 predictions in ophthalmology for 2017The great thing about making predictions is that it is basically a win-win proposition: if you are correct in your predictions, you are celebrated for being a sage. If you are incorrect, you have the opportunity to learn from them and make better predictions for the next year. Wishing everyone a Happy New Year and a successful 2017!
16 most popular stories of 2016
16 most popular stories of 2016Here is your roundup of what made top news in 2016!
LENSAR files for bankruptcy with PDL BioPharma support
LENSAR files for bankruptcy with PDL BioPharma supportLENSAR Inc. announced its filing of a Chapter 11 bankruptcy petition on Dec. 19 to reduce its debt, strengthen its balance sheet, and strengthen its platform for future growth, according to a press release from the company.
NSAID after Dropless approach shown to lower CMEThere was clinically significant less CME in patients who received trans-zonular triamcinolone acetonide, moxifloxacin hydrochloride, and vancomycin—known as the Dropless approach—in addition to an NSAID after cataract surgery.
Know your options when expanding a pupilHumans are creatures of habit, even ophthalmologists. Having learned to use one device for pupil expansion, it is easy to forget that there are alternative devices.